0% found this document useful (0 votes)
33 views6 pages

MSDS-Megaflex-PU25

The document is a Safety Data Sheet for MEGAFLEX PU25, a 1K-Polyurethane sealant/adhesive used for elastic joints, produced by N.P.T. S.r.l. It outlines hazards, first aid measures, handling and storage guidelines, and environmental impact, indicating that the product is harmful and may cause sensitization by inhalation. Proper protective measures, disposal methods, and exposure controls are emphasized to ensure safety during use.

Uploaded by

acc.solenadmall
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
33 views6 pages

MSDS-Megaflex-PU25

The document is a Safety Data Sheet for MEGAFLEX PU25, a 1K-Polyurethane sealant/adhesive used for elastic joints, produced by N.P.T. S.r.l. It outlines hazards, first aid measures, handling and storage guidelines, and environmental impact, indicating that the product is harmful and may cause sensitization by inhalation. Proper protective measures, disposal methods, and exposure controls are emphasized to ensure safety during use.

Uploaded by

acc.solenadmall
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 6

Version: 2.0 dated 13.01.

11
Revision Date: 13.05.2011
Printed On: 14.05.11

N.P.T. S.r.l.
New Polyurethane Technologies

Safety Data Sheet


Directive 1907/2006/CE (REACH)

MEGAFLEX PU25
1) IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

1.1 Identification of the substance or mixture:


Name: MEGAFLEX PU25
Description: 1K-Polyurethane sealant/adhesive
1.2 Use of substance/mixture: for elastic joints
1.3 Company/undertaking identification
N.P.T. S.r.l.
New Polyurethane Technologies
Via Guido Rossa, 2
40056 Crespellano (BO) - Italy
Tel. +39051969109 Fax: +39051969837
Responsible person of MSDS: [email protected]
1.4 Emergency telephone
Emergency service 24h Centro Antiveleni- 0382 24444

2) HAZARDS IDENTIFICATION

2.1 Classification according to EU/548/CEE o 1999/45/CE


Xn Harmful
R 42 May cause sensitization by inhalation
2.2 Labelling
Hazard symbol
Xn Harmful
Risk Phrases
R 42: May cause sensitization by inhalation
S-Phrases
S 23: Do not breathe gas/fumes/vapour/spray
S 36: Wear suitable protective clothing
S 45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
S 60 This product and its container must be disposed of as hazardous waste
Contains: 4,4’- Diphenylmethane-diisocyanate (MDI)
Consult information supplied by the manufacturer.
2.3Other risks
None available

3) COMPOSITION/INFORMATION ON INGREDIENTS
3.1 Substance
Not classified as substance
3.2 Mixture
This product is a mixture
1
MEGAFLEX PU25 Page 2 Version 1.0 del 13.01.11
Revision Date: 13.05.2011
Printed on : 14.05.11

PRODUCT % CAS N°. EINCS N° ‘R’ PHRASES SYMBOL

Xylene, mixed isomers 4,0-9,0 1330-20-7 215-535-7 R10-20/21-38 Xn

4-4’ difenilmethane 0,1-1,0 101-68-8 202-966-0 R20-/36/37/38-40- Xn


diisocyanate, mixed isomers 48/20-42/43

See Chapter 16 for further information on ‘R’ - Risk Phrases.

4) FIRST AID MEASURES


4.1 First aid measures description
Eye Contact:
In the case of product contact with eyes, immediately rinse carefully with plenty of water (remove contact lenses,
if any) and consult a doctor.
Skin Contact:
In the case of product contact with skin, remove by hand, and wash carefully with plenty of soap and water.
Ingestion:
In the case of ingestion it is necessary to consult a doctor. Do not induce vomiting unless directed to do so by
medical personnel.
Inhalation:
Move person to fresh air. If there are breathing problems, effect artificial respiration; if by mouth to mouth, use
protection (pocket mask, etc). If breathing is difficult, then oxygen should be administered by qualified personnel.
4.2 Symptoms and effects
Ingestion: N.A
Eye contact: N.A
MEDICAL NOTES:
If you are sensitized to diisocyanates, consult your physician regarding working with other respiratory irritants or
sensitizers. No specific antidote. Treatment of exposure should be directed at the control of symptoms and the
clinical condition of the patient.

5) FIRE-FIGHTING MEASURES
5.1 Extinguishing methods
Anti-fire powder, nebulised water, carbon dioxide
In the case of fire the following substances may form: carbon monoxide, nitric oxide, cyanidric acid.
5.2 Special danger from the mixing
None
5.3 Special protective equipment for fire-fighting teams
None

6) ACCIDENTAL RELEASE MEASURES


6.1 Personal precautions
Wear gloves
6.2 Environmental precaution
Do not dispose of in drains.
6.3 Clearance Methods
Clean away leakage mechanically; cover leakage with damp absorbent material ( e.g.: sawdust, reactive chemical
binders based on calcium hydrate silicate, sand ). After 1 hour, collect in a waste container. Do not close ( it
develops carbon dioxide). Keep humid and leave for many days in the open air, in a controlled area.
MEGAFLEX PU25 Page 3 Version 1.0 del 13.01.11
Revision Date: 13.05.2011
Printed on : 14.05.11

Further disposal by incineration in accordance with European and local laws in force. See Section 13.

7) HANDLING AND STORAGE


7.1 Handling
Provide sufficient air ventilation/aspiration in working areas. Avoid contact with skin, eyes and clothes. Do not eat,
drink nor smoke during use.
7.2 Storage
The storage temperature should be between + 5°C e + 35°C.
It should be kept dry and airtight closed in a cool airy place which is protected from sunlight.
7.3 Specific use(s)
For more details please refer to the Technical Data Sheet

8) EXPOSURE CONTROL/PERSONAL PROTECTION


8.1 Exposure limit values
COMPONENT LIST TYPE VALUE
4,4’ METHYLENEDIPHENYL UK WEL TWA 5 mg/m3
DIISOCYANATE; DIPHENYLMETHANE -4,4’ Ireland OELV TWA as NCO 0.02 mg/m3 –R-SEN
DIISOCYANATE (MDI)
Ireland OELV STEL as NCO 0.07 mg/m3 R-SEN
ACGIH TWA 0.005 mg/m3 R-SEN
Xylene WEL TWA 434 mg/m3 R-SEN
WEL STEL 651 mg/m3 R-SEN
ACGIH TWA 100 ppm
ACGIH STEL 150 ppm

R-SEN : Notation following the exposure guideline refers to the potential to produce respiratory sensitization, as confirmed by human or animal
data. TWA: Time Weighted Average, OELV: Occupational Exposure Limit, STEL . Short Term Exposure Limit, ACGIH: American Conference of
Governmental Industrial Hygenists Inc., WEL: Workplace Exposure Limit
8.2 Exposure Controls
8.2.1 Occupational exposure controls
Respiratory Protection
Atmospheric levels should be maintained below the exposure guideline. When atmospheric levels may exceed the
exposure guideline, use an approved air-purifying respirator equipped with an organic vapour absorbent and a
particle filter. .
Hand protection
Use chemical resistant gloves classified under Standard EN374: Protective gloves against chemicals. Examples of
preferred glove barrier materials include: Butyl rubber. Polyethylene. Chlorinated polyethylene. Ethyl vinyl alcohol
laminate ("EVAL"). Examples of acceptable glove barrier materials include: Viton. Neoprene. Natural rubber
(latex"). Polyvinyl chloride ("PVC" or "vinyl"). Nitryl/butadiene rubber ("nitryl" or"NBR").
Eye Protection
Use chemical-proof glasses – which should conform to the Directive 89/686/EEC Cat.2. Ensure that an eye-wash
fountain is close at hand.
Skin Protection
Wear protective working clothes.
8.2.2 Environmental exposure controls
Ventilation
Use only with adequate ventilation. Local exhaust ventilation may be necessary for some operations. Provide
general and/or local exhaust ventilation to control airborne levels below the exposure guidelines. Exhaust systems
should be designed to move the air away from the source of vapour/aerosol generation and people working at this
point. The odour and irritancy of this material are inadequate to warn of excessive exposure.

9) PHYSICAL AND CHEMICAL PROPERTIES


MEGAFLEX PU25 Page 4 Version 1.0 del 13.01.11
Revision Date: 13.05.2011
Printed on : 14.05.11

9.1 General Information


Appearance/Physical State Paste
Odour light typical
9.2 Important health, safety and environmental information
Ph Not Applicable
Autoignition Temperature (°C) > 250 °C
Boiling Point Not Applicable
Flash Point > 200°C
Flammability (Solid/Gas) Not Available
Lower Explosion Limit Not Available
Higher Explosion Limit Not Available
Oxidising Properties Not Applicable
Relative Density Approx. 1.3 gr/ml
Vapour Pressure N.A.
Solubility In Water (20°C) Not Soluble: Reacts
Solubility In Organic Solvents (20°C) Complete
Partition Coefficient N-Octanol/Water Not Applicable
Viscosity Not Available
Vapour Density Not Applicable
Evaporation Rate Not Available
V.O.C. 54.96 g/l
9.3 Other Information
No other information

10) STABILITY AND REACTIVITY


Chemical Stability
Product remains stable if handled and contained in recommended storage conditions
10.1 Conditions to avoid
Avoid excessive heat – as some components of this product can decompose at elevated temperatures.
10.2 Materials to avoid
Acids. Alcohols. Amines. Bases. Strong Oxidizers. Water.
10.3 Hazardous decomposition products
MDI base products react with many substances by generating heat, such as: chemical bases (e.g. caustic soda),
ammonia, primary and secondary amine, alcohol, water and acids. MDI base products are insoluble in water and as
they are denser than water, precipitate to the bottom, slowly reacting on the interface. The reaction forms a solid
polyurea layer which is not soluble in water and which releases carbon dioxide.

11) TOXICOLOGICAL INFORMATION


11.1 Information on toxicological effects
Ingestion
Toxicity caused by a single oral dosage is low. The oral LD50 for rats is >2000 mg/kg. (body weight).; however,
swallowing larger amounts may cause injury. Symptoms include: nausea , vomiting and abdominal discomfort or
diarrhoea.
Contact with Eyes
May cause irritation.
Contact with Skin
Skin sensitivity such as redness and staining can be developed following prolonged and repeated contact but is
unlikely to result in absorption of harmful amounts. The dermal LD50 has not been determined.
Inhalation
At room temperature, exposure to vapour is minimal due to low volatility; vapour from heated material or mist
may cause respiratory sensitization and other effects on health. For some components/s, excessive exposure may
cause irritation to upper respiratory tract (nose and throat) and lungs. May cause pulmonary edema (fluid in
lungs). Decreased lung function has been associated with over-exposure to isocyanates. Effects may be delayed.
MEGAFLEX PU25 Page 5 Version 1.0 del 13.01.11
Revision Date: 13.05.2011
Printed on : 14.05.11

This material contains mineral and/or inorganic fillers. There is essentially no potential for inhalation exposure to
these fillers incidental to industrial handling due to the physical state.
SENSITIZATION
Skin
Allergic skin reactions can be caused by a component in this preparation. Laboratory studies on animals have
shown that skin contact with isocyanates may effect respiratory sensitization.
Respiratory
A component in this mixture may cause an allergic respiratory response. MDI concentrations below the exposure
guidelines may cause allergic respiratory reactions in individuals already sensitized. Asthma-like symptoms may
include coughing, difficult breathing and a feeling of tightness in the chest.
Repeated Dose Toxicity
Tissue injury in the upper respiratory tract and lungs has been observed in laboratory animals after repeated
excessive exposures to MDI/POLYMERIC MDI aerosols. Contains component/s which have been reported to cause
effects on the following organs in animals: liver, kidney.
Carcinogenicity and Chronic Toxicity
Lung tumours have been observed in laboratory animals exposed to aerosol droplets of MDI/POLYMERIC MDI
(6mg/m3) for their lifetime. Tumours occurred concurrently with respiratory irritation and lung injury.
Foetal Development Toxicity
Contains component/s which has not caused birth defects in animals, other foetal effects occurred only at doses
toxic to mother.
Reproductive Toxicity
N.A
Genetic Toxicology
Genetic toxicity data on MDI are inconclusive. MDI was weakly positive in some vitro studies, other in vitro studies
were negative. Animal mutagenic studies were found to be generally negative .

12) ECOLOGICAL INFORMATION


12.1 Ecotoxicity
For the component: 4,4’-Methylenediphenyl diisocyanate; diphenylmethane-4,4’ -diisocyanate (MDI)
In the aquatic and terrestrial environment, movement is expected to be limited by its reaction with water forming
predominantly insoluble polyureas (which appear to be stable). In the atmospheric environment, material is
expected to have a short tropospheric half-life, based on calculations and by analogy with related diisocyanates.
12.2 Mobility
For the component: 4,4’-Methylenediphenyl diisocyanate; diphenylmethane-4,4’ -diisocyanate (MDI)
In the aquatic environment and terrestrial its diffusion is limited because of the reaction with water forming
insoluble polyureas
12.3 Persistence and degradability
For the component: 4,4’-Methylenediphenyl diisocyanate; diphenylmethane-4,4’ -diisocyanate (MDI)
In the aquatic environment and terrestrial its diffusion is limited because of the reaction with water forming
insoluble stable polyureas. In the atmospheric the material has a short life time.
12.4 Bioaccumulative potential
No data avalaible
12.5 Results of PBT assessment
For the component: 4,4’-Methylenediphenyl diisocyanate; diphenylmethane-4,4’ -diisocyanate (MDI)
The substance is not considered PBT
12.6 Other adverse effects
No data available

13) DISPOSAL CONSIDERATIONS


13.1 Waste treatment methods
The generation of waste should, if possible, be avoided or minimized. The recommended waste disposal method is
by incineration in controlled and approved conditions, using suitable incinerators especially designed for the
disposal of dangerous chemical waste. The empty containers should be left in the open air in order to allow
complete polymerisation and then delivered to an authorized recycling company. All disposal methods must
MEGAFLEX PU25 Page 6 Version 1.0 del 13.01.11
Revision Date: 13.05.2011
Printed on : 14.05.11

comply with EU Directives 91/156/EEC, 91/689/EEC and further modifications in line with National Laws and
Regulations.
Type of waste
Cured: Adhesive/sealant waste C.E.R. code 080410
Not cured Polyurethane adhesive code 080402

14) TRANSPORT INFORMATION


Rail and Road Transport:
ADR/RID Product not considered as dangerous goods
Product name: MEGAFLEX PU25
Marine Transport:
IMDG Product not considered as dangerous goods
N.ONU
SEA POLLUTION: Not dangerous
EXACT TECHNICAL NAME: Polyurethane resin based sealant
Air Transport:
ICAO/IATA Product not considered as dangerous goods
N.ONU
EXACT TECHNICAL NAME : Polyurethane sealant
Further Information:
Not dangerous for transport
MEGAFLEX PU25 does not produce vapour or dust. Transport in a dry
environment.
15) REGULATORY INFORMATION
15.1 Health and Safety specific norms
All the ingredients of this product are in the EINECS list or are exempt to be

16) OTHER INFORMATION


No further technical information provided.
R-Phrases referred to chapter 3
R10: Flammable
R20/21: Harmful by inhalation and skin contact
R36/37/38: Irritating to eyes, respiratory system and skin.
R40: Limited evidence of a carcinogenic effect.
R42/43: May cause sensitisation by inhalation and contact with skin.
R48/20: Harmful: danger of serious damage to health by prolonged exposure through inhalation.

The information contained in this Safety Data Sheet is provided in accordance with the National Chemical
Regulations and EU –Directives. The product should not be used for purposes other than those shown in Section 1
without first referring to the supplier and obtaining written handling instructions. As the specific conditions of use
of the product are outside the supplier’s control, the user is responsible for ensuring that the requirements of
relevant laws are complied with.

The information contained in these sheets is based on the present state of knowledge and current national
legislation. It provides guidance on health, safety and environmental aspects and should not be construed as
any guarantee of technical performance or suitability for particular applications.

You might also like